CVS Health Co. (NYSE:CVS) Shares Bought by Persium Advisors LLC

Persium Advisors LLC grew its holdings in shares of CVS Health Co. (NYSE:CVS) by 14.4% during the first quarter, Holdings Channel.com reports. The firm owned 8,225 shares of the pharmacy operator’s stock after buying an additional 1,035 shares during the quarter. Persium Advisors LLC’s holdings in CVS Health were worth $557,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of CVS. LaFleur & Godfrey LLC increased its holdings in shares of CVS Health by 49.9% during the fourth quarter. LaFleur & Godfrey LLC now owns 4,836 shares of the pharmacy operator’s stock valued at $217,000 after purchasing an additional 1,610 shares during the period. Mirae Asset Global Investments Co. Ltd. grew its holdings in CVS Health by 25.1% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 132,645 shares of the pharmacy operator’s stock worth $5,884,000 after acquiring an additional 26,589 shares during the period. Cidel Asset Management Inc. grew its holdings in CVS Health by 7.9% during the fourth quarter. Cidel Asset Management Inc. now owns 31,943 shares of the pharmacy operator’s stock worth $1,434,000 after acquiring an additional 2,341 shares during the period. Vest Financial LLC grew its holdings in CVS Health by 18.3% during the fourth quarter. Vest Financial LLC now owns 9,630 shares of the pharmacy operator’s stock worth $432,000 after acquiring an additional 1,492 shares during the period. Finally, Cantor Fitzgerald Investment Advisors L.P. grew its holdings in CVS Health by 6.0% during the fourth quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 404,443 shares of the pharmacy operator’s stock worth $18,155,000 after acquiring an additional 22,926 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms recently issued reports on CVS. Argus set a $77.00 target price on CVS Health in a report on Tuesday, February 18th. JPMorgan Chase & Co. lifted their target price on CVS Health from $80.00 to $81.00 and gave the stock an “overweight” rating in a report on Tuesday, February 18th. Barclays set a $79.00 target price on CVS Health and gave the stock an “overweight” rating in a report on Monday, June 2nd. Cowen reissued a “buy” rating on shares of CVS Health in a research note on Monday, May 5th. Finally, Wall Street Zen raised CVS Health from a “hold” rating to a “buy” rating in a research note on Friday, May 9th. Two investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $74.75.

CVS Health Trading Up 0.8%

Shares of NYSE CVS opened at $63.61 on Friday. CVS Health Co. has a one year low of $43.56 and a one year high of $72.51. The firm has a market capitalization of $80.47 billion, a PE ratio of 17.38, a PEG ratio of 0.98 and a beta of 0.56. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The business has a 50-day moving average price of $65.21 and a two-hundred day moving average price of $59.90.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The firm had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. During the same period last year, the company posted $1.31 EPS. The business’s quarterly revenue was up 7.0% compared to the same quarter last year. As a group, analysts predict that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were given a dividend of $0.665 per share. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 4.18%. CVS Health’s payout ratio is presently 63.48%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.